A glimmer of hope for older people with acute myeloid leukaemia

Affiliations

¹ Hematology Department, University Hospital Marqués de Valdecilla, Research Institute of Marqués de Valdecilla (IDIVAL), Cantabria University, Santander 39008, Spain. Electronic address: maranzazu.bermudez@scsalud.es.
² Hematology Department, University Hospital Marqués de Valdecilla, Research Institute of Marqués de Valdecilla (IDIVAL), Cantabria University, Santander 39008, Spain.

Comment

Arancha Bermúdez et al. Lancet Haematol. 2020 Oct.

. 2020 Oct;7(10):e700-e701.

doi: 10.1016/S2352-3026(20)30279-9. Epub 2020 Sep 5.

¹ Hematology Department, University Hospital Marqués de Valdecilla, Research Institute of Marqués de Valdecilla (IDIVAL), Cantabria University, Santander 39008, Spain. Electronic address: maranzazu.bermudez@scsalud.es.
² Hematology Department, University Hospital Marqués de Valdecilla, Research Institute of Marqués de Valdecilla (IDIVAL), Cantabria University, Santander 39008, Spain.

No abstract available

Comment on

10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.
DiNardo CD, Maiti A, Rausch CR, Pemmaraju N, Naqvi K, Daver NG, Kadia TM, Borthakur G, Ohanian M, Alvarado Y, Issa GC, Montalban-Bravo G, Short NJ, Yilmaz M, Bose P, Jabbour EJ, Takahashi K, Burger JA, Garcia-Manero G, Jain N, Kornblau SM, Thompson PA, Estrov Z, Masarova L, Sasaki K, Verstovsek S, Ferrajoli A, Weirda WG, Wang SA, Konoplev S, Chen Z, Pierce SA, Ning J, Qiao W, Ravandi F, Andreeff M, Welch JS, Kantarjian HM, Konopleva MY. DiNardo CD, et al. Lancet Haematol. 2020 Oct;7(10):e724-e736. doi: 10.1016/S2352-3026(20)30210-6. Epub 2020 Sep 5. Lancet Haematol. 2020. PMID: 32896301 Free PMC article. Clinical Trial.